AstraZeneca and Trump Administration to Announce Drug Pricing Deal

AstraZeneca is set to announce a significant drug pricing deal with the Trump administration, aimed at lowering medication costs for millions of Americans. This agreement reflects ongoing efforts to make healthcare more affordable, especially as many face high prescription prices. The collaboration may set a precedent for future negotiations in the pharmaceutical industry, following similar agreements with other companies like Pfizer.